Women who were exposed in utero to diethylstilbestrol (DES) have an increased chance of early menopause, according to a study in the Oct. 1 issue of the 

Elizabeth E. Hatch, PhD, of Boston University School of Public Health, and colleagues conducted a study of 4,210 DES-exposed women and 1,829 non-exposed controls. They found that those in the former group were 50% more likely to experience earlier menopause compared with their non-exposed counterparts. 

The effect was dose-dependent. Among those exposed to more than 10,000 mg, there was a more than twofold risk. The most affected were the daughters of women in the Dieckmann cohort who participated in a clinical trial of DES in the early 1950s. 

Hatch EE, Triosi R, Wise LA, et al. Age at natural menopause in women exposed to diethylstilbestrol in utero. 

News

Women who were exposed in utero to diethylstilbestrol (DES) have an increased chance of early menopause, according to a study in the Oct. 1 issue of the American Journal of Epidemiology.